OPORTUZUMAB MONATOX
UNII 945CY7ZMI2

Substance Identification & Data

This profile provides standardized clinical and technical data for Oportuzumab Monatox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 945CY7ZMI2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 945228-48-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

945CY7ZMI2

CAS Registry Number

945228-48-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OPORTUZUMAB MONATOX

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C61307

National Cancer Institute reference terminology for clinical and research data.

INN ID

9045

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-52

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oportuzumab Monatox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OPORTUZUMAB MONATOX

Common Names & Synonyms

ANTI-EPCAM ANTIBODY FRAGMENT-PSEUDOMONAS-EXOTOXIN FUSION PROTEIN

IMMUNOGLOBULIN G, ANTI-(TUMOR ANTIGEN 17-1A) (HUMAN-MOUSE SINGLE CHAIN FRAGMENT) FUSION PROTEIN WITH 252-608-EXOTOXIN A (SYNTHETIC PSEUDOMONAS)

IMMUNOGLOBULIN SCFV FUSION PROTEIN, ANTI-(HOMO SAPIENS TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1 (TACSTD1, GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN 2, GA733-2, EPITHELIAL GLYCOPROTEIN 2, EGP2, EPITHELIAL CELL ADHESION MOLECULE EP-CAM, KSA, KS1/4 ANTIGEN, M4S1, TUMOR ANTIGEN 17-1A, CD326)) HUMANIZED MONOCLONAL ANTIBODY SCFV FUSED WITH PSEUDOMONAS AERUGINOSA EXOTOXIN A; HEXAHISTIDYL-HUMANIZED SCFV (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (78%)-IGKJ1*01, I126>L) (11.3.9) (7-118)-26-MER LINKER-VH (HOMO SAPIENS IGHV7-4-1*02-(IGHD)-IGHJ4*01, V124>L) (8.8.9) (145-260))-20-MER LINKER-PSEUDOMONAS AERUGINOSA EXOTOXIN A (ETA) (277-633 PRECURSOR FRAGMENT, CONTAINING DOMAIN II (281-393) WITH FURIN PROTEOLYTIC CLEAVAGE SITE (302-313), DOMAIN IB (394-433), DOMAIN III (434-637)) (281-637)-HEXAHISTIDYL-LYSYL-ASPARTYL-GLUTAMYL-LEUCYL

MOAB, HUMANIZED, SINGLE CHAIN:PSEUDOMONAS EXOTOXIN A IMMUNOTOXIN FUSION PROTEIN, VB4-845 TO EPCAM

OPORTUZUMAB MONATOX [INN]

OPORTUZUMAB MONATOX [USAN]

OPORTUZUMAB MONATOX [WHO-DD]